Proceedings of the 3rd International Conference on Cardiovascular Diseases (ICCvD 2021)

Type 2 Cardiorenal Syndrome in Heart Failure with NSTEMI: A Case Report of 10 Months Follow Up

Authors
Achmad Bima Aryaputra1, Dewi Hapsari Suprobo2, Erlina Marfianti3, *
1General Practitioner, RSU Islam Klaten, Klaten, Indonesia
2Department of Cardiology and Vascular Medicine, RSU Islam Klaten, Klaten, Indonesia
3Department of Internal Medicine, Faculty of Medicine, Universitas Islam Indonesia, Yogyakarta, Indonesia
*Corresponding author. Email: erlina.marfianti@uii.ac.id
Corresponding Author
Erlina Marfianti
Available Online 19 December 2022.
DOI
10.2991/978-94-6463-048-0_40How to use a DOI?
Keywords
Cardiorenal Syndrome; Heart Failure; Chronic Kidney Disease; Hemodialysis
Abstract

Cardiorenal syndrome (CRS) is a disorder of the heart and kidneys whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction of the other. Chronic abnormality in cardiac function leading to kidney injury or dysfunction was a typical characteristic of CRS type 2. Renal dysfunction frequently coexists with chronic heart disease, which in this situation, it’s often difficult to establish which of the 2 diseases is the primary one. We present the case of a 74-years old male was presented with chest pain, cough, dyspnee d'effort, and diaphoresis. He had a history of chronic heart failure, atrial fibrillation, and renal insufficiency. Chest radiography revealed pulmonary edema. The electrocardiogram showed Atrial Fibrillation (AF) with Left Bundle Branch Block (LBBB). On echocardiography we found RWMA (+), ejection fraction of 24%, TAPSE 12 mm. Initial laboratory result was a high concentration of urea and diminished renal function shown as a high concentration of creatinine with eGFR was 16.1 mL/min/1.73 m2 (MDRD) and Troponin I was 630 ng/L. He was transferred to ICU with NSTEMI, heart failure, renal insufficiency, and AF with LBBB. Patient was treated with Digoxin, intravenous Furosemide, Aspirin, Clopidogrel, Candesartan, Carvedilol, Rosuvastatin, Curcuma and Aminoral. On the next day, dopamine was given due to hypotension. Three days later, there’s improvement in kidney condition and urine output. Patient felt neither chest pain nor dyspnea. On the 6th day, the patient was discharged. An adequate treatment of heart failure in cardiorenal syndrome can also improve renal condition.

Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

Volume Title
Proceedings of the 3rd International Conference on Cardiovascular Diseases (ICCvD 2021)
Series
Advances in Health Sciences Research
Publication Date
19 December 2022
ISBN
978-94-6463-048-0
ISSN
2468-5739
DOI
10.2991/978-94-6463-048-0_40How to use a DOI?
Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

TY  - CONF
AU  - Achmad Bima Aryaputra
AU  - Dewi Hapsari Suprobo
AU  - Erlina Marfianti
PY  - 2022
DA  - 2022/12/19
TI  - Type 2 Cardiorenal Syndrome in Heart Failure with NSTEMI: A Case Report of 10 Months Follow Up
BT  - Proceedings of the 3rd International Conference on Cardiovascular Diseases (ICCvD 2021)
PB  - Atlantis Press
SP  - 345
EP  - 354
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-048-0_40
DO  - 10.2991/978-94-6463-048-0_40
ID  - Aryaputra2022
ER  -